Onytec
Ciclopirox Medicated Nail Lacquer for Fungal Nail Infections
Quick Facts About Onytec
Key Takeaways
- Onytec is a once-daily medicated nail lacquer containing ciclopirox 8% for treating mild to moderate fungal nail infections in adults.
- No nail filing or solvent removal is needed — the lacquer is easily washed off with water, making it convenient for daily use.
- Treatment typically lasts 6 months for fingernails and 9–12 months for toenails; consistency is essential for successful outcomes.
- Side effects are very rare and mostly limited to local skin reactions such as redness, peeling, or itching at the application site.
- Not suitable for children under 18 years, severe infections involving the nail growth zone, or for use with cosmetic nail products during treatment.
What Is Onytec and What Is It Used For?
Onytec belongs to a group of medicines called antifungal agents, specifically the hydroxypyridone class. The active ingredient, ciclopirox, has broad-spectrum antifungal activity against the dermatophytes, yeasts, and moulds that most commonly cause fungal nail infections. Unlike many antifungal treatments that work through a single mechanism, ciclopirox disrupts multiple cellular processes in the fungal organism, making it effective against a wide range of pathogenic fungi.
Fungal nail infections, medically known as onychomycosis, are among the most prevalent nail disorders worldwide, affecting approximately 5.5% of the global population according to epidemiological data. The condition is characterised by thickening, discolouration, brittleness and deformation of affected nails. Toenails are affected far more commonly than fingernails, largely due to the warm, moist environment inside shoes that promotes fungal growth. The condition becomes more common with age, with prevalence rising to over 20% in individuals aged 60 and above.
Onytec is specifically indicated for the treatment of mild to moderate nail fungal infections in adults where the infection affects up to 75% of the nail surface, involves no more than 5 nails (including both toenails and fingernails), and critically, does not involve the nail growth zone. The nail growth zone, also called the nail matrix and lunula (the white half-moon visible at the base of the nail), must be unaffected for Onytec to be an appropriate treatment choice. When the matrix is involved, the infection is considered more severe and typically requires oral antifungal therapy instead.
The formulation of Onytec as a water-soluble nail lacquer represents an important advance over earlier ciclopirox nail lacquer products. The hydroxypropyl chitosan vehicle in Onytec facilitates penetration of the active ingredient through the nail plate while allowing easy removal with water. Older formulations required removal with organic solvents or regular nail filing, which many patients found inconvenient and which sometimes led to reduced treatment adherence. The ability to simply wash off Onytec with water, without the need for filing or solvents, significantly improves the user experience and may contribute to better treatment outcomes through improved compliance.
How Does Ciclopirox Work?
Ciclopirox exerts its antifungal effect through a unique mechanism of action that differs from other commonly used antifungals such as azoles or allylamines. Rather than targeting a single enzyme pathway, ciclopirox acts by chelating (binding) polyvalent metal cations, particularly iron (Fe3+) and aluminium (Al3+), that serve as essential cofactors for numerous metalloenzymes within the fungal cell. By depleting these essential metal ions, ciclopirox disrupts multiple metabolic processes simultaneously, including energy production via the mitochondrial electron transport chain, cell membrane integrity, and the synthesis of essential macromolecules.
This multi-target mechanism of action provides two important clinical advantages. First, it gives ciclopirox a broader spectrum of activity compared to antifungals that target a single enzyme, meaning it is effective against dermatophytes such as Trichophyton rubrum and Trichophyton mentagrophytes, as well as yeasts like Candida albicans and various moulds. Second, the multi-target approach reduces the likelihood of resistance development, since the organism would need to develop simultaneous resistance to multiple disrupted pathways rather than a single drug target.
What Should You Know Before Using Onytec?
Contraindications
There are specific situations where Onytec must not be used. The most fundamental contraindication is a known allergy (hypersensitivity) to ciclopirox or any of the other ingredients in the formulation, including ethyl acetate, ethanol, cetostearyl alcohol, hydroxypropyl chitosan, and purified water. Cetostearyl alcohol, in particular, is known to occasionally cause local skin reactions such as contact dermatitis in sensitised individuals.
Onytec should not be used in children and adolescents under the age of 18 years. This restriction exists because there is insufficient clinical experience with the product in this age group to establish its safety and efficacy. Fungal nail infections are relatively uncommon in children, and when they do occur, paediatric management should be guided by a specialist dermatologist who can assess the most appropriate treatment approach.
- You are allergic to ciclopirox or any other ingredient in this medicine
- You are under 18 years of age
- The infection affects the nail growth zone (matrix/lunula)
- More than 75% of the nail surface is affected
- More than 5 nails are infected
Warnings and Precautions
If your nail fungal infection is more extensive than the approved indication — involving more than 75% of the nail surface, affecting more than 5 nails, or involving the nail growth zone — Onytec alone is unlikely to be sufficient and you should consult your doctor about alternative or combination therapy. More severe infections typically require oral antifungal medications such as terbinafine or itraconazole, either alone or in combination with topical therapy.
Patients with diabetes mellitus should exercise particular caution during nail care while using Onytec. Diabetes can impair circulation and sensation in the feet, increasing the risk of injury during nail trimming or manipulation. Diabetic patients should follow careful nail care practices and consider having nail care performed by a podiatrist or healthcare professional experienced in diabetic foot management.
Special consideration should also be given to individuals with a medical history of immune system disorders, peripheral vascular disease, psoriasis or other chronic skin conditions, nail damage or painful nails, or yellow nail syndrome (which may be associated with lymphoedema and respiratory conditions). These conditions can affect the nails in ways that may complicate the diagnosis and treatment of fungal infections, and medical supervision is particularly important in these circumstances.
- Avoid contact with eyes and mucous membranes (mouth, nostrils)
- For external use only — apply only to nails and immediately surrounding skin
- Do not use cosmetic nail polish or other nail products on treated nails
- Keep the bottle tightly closed when not in use
- This product is flammable — do not expose to heat or open flame
If you develop signs of hypersensitivity to the product, such as increased redness, swelling, itching, or a rash at or around the application site, you should discontinue treatment and seek medical advice. While allergic reactions to Onytec are uncommon, cetostearyl alcohol in the formulation has the potential to cause contact dermatitis in susceptible individuals.
Pregnancy and Breastfeeding
The safety of Onytec during pregnancy has not been established through adequate and well-controlled clinical studies. If you are pregnant, suspect you may be pregnant, or are planning to become pregnant, you should consult your doctor or pharmacist before using this medicine. Treatment with Onytec during pregnancy should only be undertaken if clearly necessary and specifically prescribed by a physician who has weighed the potential benefits against the potential risks.
It is not known whether ciclopirox is excreted in human breast milk following topical application of Onytec. Although systemic absorption from the medicated nail lacquer is minimal, the product should only be used during breastfeeding if it is considered absolutely necessary by the prescribing physician. Given that onychomycosis is not an urgent medical condition, it may be reasonable to defer treatment until after the breastfeeding period has ended.
Driving and Using Machines
Onytec has no known effect on the ability to drive vehicles or operate machinery. As a topical product applied to the nails with negligible systemic absorption, it does not affect cognitive function, alertness, or psychomotor performance.
How Does Onytec Interact with Other Drugs?
One of the notable advantages of topical nail lacquer formulations like Onytec is their minimal potential for systemic drug interactions. Because ciclopirox is applied directly to the nail surface and the surrounding skin, systemic absorption is extremely low. This means that the active ingredient does not reach the bloodstream in quantities sufficient to interact with other orally or parenterally administered medications.
Unlike oral antifungal agents such as itraconazole (which inhibits CYP3A4) or terbinafine (which inhibits CYP2D6), topical ciclopirox does not affect hepatic drug metabolism. This makes Onytec a particularly advantageous option for patients who are taking multiple medications and wish to avoid the risk of drug-drug interactions that can occur with systemic antifungal therapy. Elderly patients, who often take numerous medications for chronic conditions, may especially benefit from this favourable interaction profile.
Nevertheless, it is always good practice to inform your doctor or pharmacist about any medications you are currently taking, have recently taken, or may be about to take, including over-the-counter medicines, herbal remedies, and dietary supplements. While no formal interaction studies have been conducted for Onytec in combination with other topical nail products, it is recommended not to apply other topical treatments to the same nails during the treatment period, as this could potentially interfere with the penetration and effectiveness of ciclopirox.
| Interaction Category | Details | Clinical Significance |
|---|---|---|
| Systemic drugs | No known interactions due to minimal systemic absorption | None |
| Other topical nail products | Cosmetic nail polish and lacquer may reduce efficacy | Avoid concurrent use |
| CYP450 enzymes | No inhibition or induction of hepatic enzymes | None |
| Oral antifungals | Can potentially be used in combination with oral terbinafine or itraconazole under medical supervision | Possible synergistic benefit |
What Is the Correct Dosage of Onytec?
Adults
The recommended dosage for adults is one thin layer applied once daily to all infected nails. Before application, the nails should be thoroughly washed and completely dried. Using the brush applicator provided with the bottle, apply the medicated nail lacquer evenly over the entire nail surface, extending approximately 5 mm onto the surrounding skin. Where possible, the lacquer should also be applied underneath the free edge of the nail, as fungal organisms often reside in this space.
Step-by-Step Application
- Wash and dry the affected nails thoroughly before application
- Apply a thin layer of Onytec over the entire nail surface using the brush applicator
- Extend the application 5 mm onto the surrounding skin
- Apply under the free edge of the nail where possible
- Allow to dry for approximately 30 seconds
- Do not wash treated nails for at least 6 hours
It is recommended to apply Onytec in the evening before bedtime. This timing ensures that the lacquer remains in contact with the nail undisturbed for the required minimum of 6 hours before washing. After the 6-hour period, normal hygiene routines can be followed. Unlike some other medicated nail lacquers, Onytec does not need to be removed with solvents or nail filing — it is simply washed away with water during normal bathing. If the lacquer is inadvertently removed through washing before the recommended contact time, it can be reapplied.
Regular removal of loose parts of the infected nail is recommended throughout the treatment period. This can be achieved through routine nail clipping and trimming. Removing damaged or detached nail material helps to reduce the fungal burden and allows the medicated lacquer to access deeper layers of the nail bed more effectively.
Children
Onytec is not approved for use in children and adolescents under 18 years of age due to insufficient clinical data in this population. If a child or adolescent is suspected of having a fungal nail infection, a dermatologist or paediatric specialist should be consulted for appropriate diagnosis and management.
Elderly
No dosage adjustment is required for elderly patients. The same once-daily application regimen applies. However, elderly individuals should be aware that nail growth slows with age, which means treatment duration may be longer. Toenail growth in older adults can take 12–18 months for a complete nail replacement cycle, so patience and consistent application are especially important in this population. Elderly patients with impaired dexterity may benefit from assistance with application.
Treatment Duration
| Nail Type | Typical Duration | Notes |
|---|---|---|
| Fingernails | Approximately 6 months | Fingernails grow faster than toenails |
| Toenails | 9–12 months | Toenails grow more slowly; most common site of infection |
| Elderly patients | Up to 18 months | Slower nail growth may extend treatment time |
Treatment should continue until the affected nail has cleared (no discolouration) or its appearance has improved noticeably and healthy nail has grown out. Stopping treatment prematurely, before the infection has been fully eradicated, risks allowing the fungus to persist and the infection to recur or worsen.
Missed Dose
If you forget to apply Onytec on one occasion, do not apply a double dose to compensate. Simply continue with the next scheduled application as normal. Missing a single dose is unlikely to significantly affect the overall treatment outcome. However, if multiple consecutive days are missed, the effectiveness of the treatment may be reduced. In such cases, resume daily application as soon as possible and continue with the regular regimen.
Overdose
In the event that the nail lacquer is accidentally swallowed, seek immediate medical attention at the nearest hospital emergency department. Take the Onytec packaging with you to assist healthcare professionals. Due to the topical nature of the product, overdose from normal nail application is not expected. Ciclopirox has low systemic toxicity, but accidental ingestion should still be treated as a medical matter requiring professional evaluation.
What Are the Side Effects of Onytec?
Like all medicines, Onytec can cause side effects, although not everybody experiences them. The topical route of administration and minimal systemic absorption mean that side effects are almost exclusively confined to the site of application. The overall safety profile of topical ciclopirox nail lacquer has been well-established through clinical trials and post-marketing surveillance data spanning many years of use.
It is worth noting that some changes in the appearance of the nail during treatment — such as mild discolouration — may be attributable to the fungal infection itself resolving rather than to a side effect of the medication. As the infected nail grows out and is replaced by healthy nail, you may notice colour changes that are part of the normal healing process. If you are uncertain whether a change represents a side effect or a sign of improvement, consult your doctor or pharmacist.
Very Rare
May affect up to 1 in 10,000 users
- Redness at the application site
- Skin peeling around the treated nail
- Burning sensation at the application site
- Itching at the application site
Not Known
Frequency cannot be estimated from available data
- Skin rash
- Eczema
- Allergic dermatitis (skin inflammation), which may also occur beyond the application site
- Transient nail discolouration (note: the fungal infection itself can also cause this)
If you experience any of the side effects listed above, or if you notice any other unusual symptoms during treatment, inform your doctor or pharmacist. This is particularly important for allergic-type reactions (such as rash, eczema, or dermatitis spreading beyond the application site), which should prompt discontinuation of treatment and medical review.
Reporting suspected adverse reactions after a medicine has been authorised is an important practice. It allows for continued monitoring of the benefit-risk balance of the medicine. Healthcare professionals and patients are encouraged to report any suspected adverse reactions to their national pharmacovigilance authority.
Managing Side Effects
Most local side effects from Onytec are mild and transient. If you experience mild redness, peeling, or itching, these symptoms often resolve on their own with continued treatment. Keeping the surrounding skin moisturised (using a fragrance-free emollient on the skin around the nail, but not on the nail itself before application) can help to minimise local irritation. If symptoms are severe, persistent, or worsening, discontinue use and consult your healthcare provider for guidance.
How Should You Store Onytec?
Proper storage of Onytec is important to maintain its effectiveness throughout the treatment period. The medicated nail lacquer should be kept in its outer carton (original packaging) at all times when not in use, as the product is light-sensitive. Exposure to prolonged or intense light can degrade the active ingredient and reduce the efficacy of the product.
The product should be stored at room temperature and protected from cold. It must not be frozen. Onytec is a flammable liquid due to its ethanol and ethyl acetate solvent base, so it must not be exposed to heat sources or open flames. Always ensure the bottle cap is tightly closed after each use to prevent evaporation of the solvent, which could alter the concentration and consistency of the lacquer.
- Keep out of sight and reach of children
- Store in the outer carton to protect from light
- Do not refrigerate or freeze
- Keep the bottle tightly closed between uses
- Use within 6 months after first opening
- Do not use after the expiry date on the carton and bottle
- Flammable — keep away from heat and open flame
If the product is stored below 15°C, the nail lacquer may become gel-like in consistency. A slight precipitate or sediment may also form. This is a normal physical change and does not affect the quality or performance of the product. To restore the lacquer to its normal liquid consistency, simply warm the bottle to room temperature (approximately 25°C) by rubbing it between your hands for about one minute until the solution becomes clear again.
Do not dispose of unused medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer needed. These measures help to protect the environment.
What Does Onytec Contain?
Understanding the composition of your medicine is important, particularly for identifying potential allergens. The active substance in Onytec is ciclopirox. Each gram of the medicated nail lacquer contains 80 mg of ciclopirox (equivalent to an 8% concentration). This concentration has been optimised through clinical research to provide effective antifungal activity while maintaining a favourable safety profile when applied to the nail.
| Ingredient | Role | Notes |
|---|---|---|
| Ciclopirox 80 mg/g | Active ingredient (antifungal) | Broad-spectrum hydroxypyridone antifungal |
| Ethyl acetate | Solvent | Aids film formation; evaporates on drying |
| Ethanol (96%) | Solvent | Aids dissolution; contributes to flammability |
| Cetostearyl alcohol | Emulsifier/stabiliser | May cause local skin reactions (e.g. contact dermatitis) |
| Hydroxypropyl chitosan | Film-forming vehicle | Biopolymer that aids nail penetration; water-soluble |
| Purified water | Solvent/vehicle | Pharmaceutical-grade water |
The hydroxypropyl chitosan in the formulation is a key technological component. Chitosan is a biopolymer derived from chitin (found in crustacean shells) that has been chemically modified to become water-soluble. It forms a thin, transparent film on the nail surface after the solvents evaporate, which serves as a reservoir for the ciclopirox active ingredient and facilitates its gradual penetration through the nail plate to the infection site beneath. This water-soluble film is what allows Onytec to be removed with simple water washing, without the need for organic solvents or abrasive filing.
Onytec is supplied as a clear, colourless to slightly yellowish solution in clear glass bottles with a screw cap incorporating a brush applicator for convenient application. The product is available in pack sizes of 3.3 ml and 6.6 ml, although not all pack sizes may be marketed in every country. The marketing authorisation holder is Polichem SA, Luxembourg, and the product is manufactured by Almirall Hermal GmbH, Germany, and Alfasigma S.p.A., Italy, among other authorised manufacturing sites.
Frequently Asked Questions About Onytec
Onytec is a medicated nail lacquer used to treat mild to moderate fungal nail infections (onychomycosis) in adults. It contains 8% ciclopirox as the active ingredient and is applied once daily to affected nails. It is suitable for infections affecting up to 75% of the nail surface on up to 5 nails, provided the nail growth zone (matrix and lunula) is not involved.
Treatment duration depends on the nail involved. Fingernail infections typically require around 6 months of treatment, while toenail infections usually need 9 to 12 months. Treatment should continue until the infected nail has cleared or significantly improved and healthy nail has grown back. Consistency is key — missing applications can reduce effectiveness.
No, Onytec does not require nail filing or removal with solvents before application. This is a key advantage over some other antifungal nail lacquers. Simply wash and dry your nails thoroughly before applying. The lacquer can be removed with ordinary water washing. However, regular trimming of loose infected nail material is recommended throughout treatment.
No, you should not use cosmetic nail polish or other cosmetic nail products on nails being treated with Onytec. Cosmetic products can interfere with the penetration and effectiveness of the medicated lacquer. Wait until treatment is complete and the nail infection has cleared before using cosmetic nail products again.
If you miss a single application, do not apply a double dose. Simply continue with your next scheduled application. Missing one day is unlikely to significantly affect treatment outcomes. However, missing several consecutive days may reduce the effectiveness of the treatment. If this occurs, resume daily application as soon as possible and continue with your regular routine.
The safety of Onytec during pregnancy has not been fully established. It should only be used during pregnancy if clearly necessary and prescribed by a doctor. It is unknown whether ciclopirox passes into breast milk. Breastfeeding mothers should only use Onytec if the benefit outweighs the risk, and only under medical supervision. As onychomycosis is not an urgent condition, treatment may be deferred until after pregnancy and breastfeeding.
References
- Baran R, Tosti A, Hartmane I, et al. An innovative water-soluble biopolymer-based medicated nail lacquer for the treatment of onychomycosis. J Dermatolog Treat. 2009;20(4):208-217.
- Gupta AK, Stec N, Summerbell RC, et al. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020;34(9):1972-1990.
- Piraccini BM, Sisti A, Tosti A. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J Am Acad Dermatol. 2010;62(3):411-414.
- European Medicines Agency (EMA). Summary of Product Characteristics: Ciclopirox nail lacquer formulations. Accessed January 2026.
- Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg. 2017;21(6):525-539.
- World Health Organization (WHO). WHO Model List of Essential Medicines. 23rd Edition, 2023.
- British Association of Dermatologists (BAD). Guidelines for the management of onychomycosis. Br J Dermatol. 2014;171(5):937-958.
- Elewski BE, Rich P, Pollak R, et al. Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2013;68(4):600-608.
- National Institute for Health and Care Excellence (NICE). Fungal nail infection: antimicrobial prescribing. NICE guideline [NG194]. 2021.
- Lipner SR, Scher RK. Onychomycosis: Treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853-867.
Medical Editorial Team
Medical Content
Written by the iMedic Medical Editorial Team — specialists in dermatology, mycology and clinical pharmacology with documented academic backgrounds and clinical experience.
Medical Review
Reviewed by the iMedic Medical Review Board — an independent panel of medical experts who review all content according to international guidelines (BAD, AAD, WHO).
Evidence Standard: All medical claims in this article are based on peer-reviewed research, international clinical guidelines, and approved product information. Evidence level: 1A (systematic reviews and randomised controlled trials). This content follows the GRADE evidence framework and is free from commercial funding or pharmaceutical industry influence.